Thursday, June 03, 2021 1:55:54 PM
As we now see there has been better evaluations of Data done by the current CSO so that there is NOW a Real reason for an EOP2 FDA meeting to consider the beneficial results of Ifenprodil. ALI / COVID PF / Long-haulers with low O2? IL-6?
Discussions of Ifenprodil's possible uses for Cancers/Tumors was brought up by CM and MW but was not followed though, until now.
Next for Ifenprodil may be the data recently posted for Stroke. Maybe to complement the DMT Micro-dose concepts. We can Hope further research is being done...JMHO...
Outdated commentary of our MicroPharma/management and it's main CT drug seems the standard.
I'll speculate on the Positive possibilities. Investors can Buy/hold/trade/sell, but we Dont run the company...GLTA...
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM